L-Arginine improves endothelial and myocardial function after brain death

Transplantation

Volumn 82, Issue 1, 2006, Pages 108-112

  Szabó, Gábor ^a,b   Soós, Pál ^a   Heger, Ulrike ^a   Mandera, Susanne ^a   Buhmann, Volker ^a   Bährle, Susanne ^a   Kohl, Brigitte ^a   Hagl, Siegfried ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Department of Cardiac Surgery ^*  (Germany)

Author keywords

Brain death; Contractility; Endothelium; Nitric oxide; Vascular function

Indexed keywords

ACETYLCHOLINE; ARGININE; NITRATE; NITRITE; NITROPRUSSIDE SODIUM; NITRIC OXIDE; VASODILATOR AGENT;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BALLOON; BLOOD LEVEL; BRAIN DEATH; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; DOG; DRUG INFUSION; ENDOTHELIAL DYSFUNCTION; HEART FUNCTION; HEART PRELOAD; HEART PROTECTION; HEART STROKE VOLUME; HEART WORK; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION; ANIMAL; BLOOD; DRUG EFFECT; HEART; HEART CONTRACTION; HEART MUSCLE; HEMODYNAMICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ARGININE; BRAIN DEATH; CORONARY CIRCULATION; DOGS; ENDOTHELIUM, VASCULAR; HEART; HEMODYNAMIC PROCESSES; MYOCARDIAL CONTRACTION; MYOCARDIUM; NITRATES; NITRIC OXIDE; NITRITES; NITROPRUSSIDE; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 33747459632     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000225778.49388.f5     Document Type: Article

References (28)

1. Novitzky D, Wicomb WN, Cooper DKC, et al. Electrocardiographic, haemodynamic, and endocrine changes occurring during experimental brain death in the Chacma baboon. Heart Transplant 1984; 4: 63.
2. Sebening C, Hagl C, Szabó G, et al. Cardiocirculatory effects of acutely increased intracranial pressure and subsequent brain death. Eur J Cardiothorac Surg 1995; 9: 360.
3. Shivalkar B, Van Loon J, Wieland W, et al. Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation 1993; 87: 230.
4. Bittner HB, Kendall SWH, Campbell KA, et al. A valid experimental brain death organ donor model. J Heart Lung Transplant 1995; 14: 308.
5. Galinanes M, Hearse DJ. Brain-death-induced cardiac contractile dysfunction: studies of possible neurohormonal and blood borne mediators. J Mol Cell Cardiol 1994; 26: 481.
6. Bruinsma GJBB, Nederhoff MGJ, Geertman HJ, et al. Acute increase of myocardial workload, hemodynamic instability and myocardial histologic changes induced by brain death in the cat. J Surg Res 1997; 68: 7.
7. Szabó G, Sebening C, Hackert T, et al. Effects of brain death on myocardial function and ischemic tolerance of potential donor hearts. J Heart Lung Transplant 1998; 17: 921.
8. Herijgers P, Borgers M, Flameng W. The effect of brain death on cardiovascular function in rats. Part I. Is the heart damaged? Cardiovasc Res 1998; 38: 98.
9. Herrijgers P, Flameng W. The effect of brain death on cardiovascular function in rats. Part II. The cause of the in vivo haemodynamic changes. Cardiovasc Res 1998; 38: 107.
10. Wheeldon DR, Potter CD, Oduro A, et al. Transforming the "unacceptable" donor: outcomes from the adoption of standardized donor management technique. J Herat Lung Transplant 1995; 14: 734.
11. Stoica SC, Satchithananda DK, Charman S, et al. Swan-Ganz catheter assessment of donor hearts: outcome of organs with borderline hemodynamics. J Heart Lung Transplant 2002; 21: 615.
12. Wilhelm MJ, Pratschke J, Beato F, et al. Activation of the heart by donor brain death accelerates acute rejection after transplantation. Circulation 2000; 102: 2426.
13. Day JD, Rayburn BK, Gaudin PB, et al. Cardiac allograft vasculopathy: The central pathogenetic role of ischemia induced endothelial cell injury. J Heart Lung Transplant 1992; 14: S142.
14. Szabó G, Bährle S, Stunpf N, et al. Poly (ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation. Circ Res 2002; 90: 100.
15. Meyer J, Richter N, Hecker M. High-performance liquid chromatographic determination of nitric oxide synthase-related arginine derivatives in vitro and in vivo. Anal Biochem 1997; 247: 11.
16. Szabó G, Hackert T, Buhmann V, et al. Downregulation of myocardial contractility via intact ventriculo-arterial coupling in the brain dead organ donor. Eur J Cardio-Thorac Surg 2001; 20: 170.
17. Szabó G. Physiological changes after brain death. J Heart Lung Transplant 2004; 23: S223.
18. Herijgers P, Leunens V, Tjandra-Maga TB, et al. Changes in organ perfusion after brain death in the rat and its relation to circulating catecholamines. Transplantation 1996; 62: 330.
19. Mertes PM, El Abassi K, Jaboin Y, et al. Changes in hemodynamic and metabolic parameters following induced brain death in the pig. Transplantation 1994; 58: 414.
20. Szabó G, Hackert T, Sebening C, et al. Modulation of coronary perfusion pressure can reverse myocardial dysfunction after brain death. Ann Thorac Surg 1999; 67: 18.
21. Sunagawa K, Maughan D, Burkhoff D, Sagawa K. Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol 1983; 254: H773.
22. Szabó G, Buhmann V, Bährle S, et al. Brain death impairs coronary endothelial function. Transplantation 2002; 73: 1846.
23. Oishi Y, Nishimura Y, Tanoue Y, et al. Endothelin-1 receptor antagonist prevents deterioration of left ventricular function and coronary flow reserve in brain-dead canine heart. J Heart Lung Transplant 2005; 24: 1354.
24. Koch A, Bingold TM, Oberlander J, et al. Capillary endothelia and cardiomyocytes differ in vulnerability to ischemia/reperfusion during clinical heart transplantation. Eur J Cardiothorac Surg 2001; 20: 996.
25. Rubanyi GM, Lorenz RR, Vanhoutte PM. Bioassay of endothelium-derived relaxing factor(s): inactivation by catecholamines. Am J Physiol 1985; 249: H95-101.
26. Vargas F, Fernandez-Rivas A, Garcia Estan J. Endothelium-dependent and endothelium-independent vasodilation in hyperthyroid and hypothyroid rats. Pharmacology 1995; 51: 308.
27. Lekakis J, Papamichael C, Alevizaki M, et al. Thyroid 1997 Jun; 7(3): 411.
28. Soós P, Andrási T, Buhmann V, et al. Myocardial protection after systemic application of L-arginine during reperfusion. J Cardiovasc Pharm 2004; 43: 782.